1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Kim, J.I.
Konishi, S.
Iwai, H.
Kohno, T.
Gouda, H.
Shimada, I.
Sato, K.
Arata, Y.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
250
659
671
10.1006/jmbi.1995.0406
7623383
Three-dimensional solution structure of the calcium channel antagonist omega-agatoxin IVA: consensus molecular folding of calcium channel blockers.
1995
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
5220.393
OMEGA-AGATOXIN IVA
1
man
polymer
no
no
KKKCIAKDYGRCKWGGTPCCRGRGCICSIMGTNCECKPRLIMEGLGLA
KKKCIAKDYGRCKWGGTPCCRGRGCICSIMGTNCECKPRLIMEGLGLA
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Agelenopsis
sample
6908
Agelenopsis aperta
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conf
repository
Initial release
Version format compliance
Version format compliance
Derived calculations
Other
1
0
1995-10-15
1
1
2008-03-24
1
2
2011-07-13
1
3
2017-11-29
_pdbx_database_status.process_site
Y
BNL
1995-06-28
REL
1
BRUNGER
refinement
X-PLOR
3.1
LYS
1
n
1
LYS
1
A
LYS
2
n
2
LYS
2
A
LYS
3
n
3
LYS
3
A
CYS
4
n
4
CYS
4
A
ILE
5
n
5
ILE
5
A
ALA
6
n
6
ALA
6
A
LYS
7
n
7
LYS
7
A
ASP
8
n
8
ASP
8
A
TYR
9
n
9
TYR
9
A
GLY
10
n
10
GLY
10
A
ARG
11
n
11
ARG
11
A
CYS
12
n
12
CYS
12
A
LYS
13
n
13
LYS
13
A
TRP
14
n
14
TRP
14
A
GLY
15
n
15
GLY
15
A
GLY
16
n
16
GLY
16
A
THR
17
n
17
THR
17
A
PRO
18
n
18
PRO
18
A
CYS
19
n
19
CYS
19
A
CYS
20
n
20
CYS
20
A
ARG
21
n
21
ARG
21
A
GLY
22
n
22
GLY
22
A
ARG
23
n
23
ARG
23
A
GLY
24
n
24
GLY
24
A
CYS
25
n
25
CYS
25
A
ILE
26
n
26
ILE
26
A
CYS
27
n
27
CYS
27
A
SER
28
n
28
SER
28
A
ILE
29
n
29
ILE
29
A
MET
30
n
30
MET
30
A
GLY
31
n
31
GLY
31
A
THR
32
n
32
THR
32
A
ASN
33
n
33
ASN
33
A
CYS
34
n
34
CYS
34
A
GLU
35
n
35
GLU
35
A
CYS
36
n
36
CYS
36
A
LYS
37
n
37
LYS
37
A
PRO
38
n
38
PRO
38
A
ARG
39
n
39
ARG
39
A
LEU
40
n
40
LEU
40
A
ILE
41
n
41
ILE
41
A
MET
42
n
42
MET
42
A
GLU
43
n
43
GLU
43
A
GLY
44
n
44
GLY
44
A
LEU
45
n
45
LEU
45
A
GLY
46
n
46
GLY
46
A
LEU
47
n
47
LEU
47
A
ALA
48
n
48
ALA
48
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
ARG
21
0.184
SIDE CHAIN
1
A
ARG
23
0.304
SIDE CHAIN
1
A
LYS
3
71.07
64.21
1
A
PRO
18
-80.73
-151.78
1
A
CYS
20
-87.56
-75.10
1
A
ARG
21
-35.51
-29.49
1
A
CYS
25
-66.57
87.25
1
A
CYS
27
-107.15
-168.86
1
A
SER
28
-88.12
30.93
1
A
ILE
29
52.19
19.38
1
A
ARG
39
28.84
98.90
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
OMEGA-AGATOXIN IVA
OMEGA-AGATOXIN IVA
1
Y
N
disulf
2.015
A
CYS
4
A
SG
CYS
4
1_555
A
CYS
20
A
SG
CYS
20
1_555
disulf
2.021
A
CYS
12
A
SG
CYS
12
1_555
A
CYS
25
A
SG
CYS
25
1_555
disulf
2.024
A
CYS
19
A
SG
CYS
19
1_555
A
CYS
36
A
SG
CYS
36
1_555
disulf
2.022
A
CYS
27
A
SG
CYS
27
1_555
A
CYS
34
A
SG
CYS
34
1_555
NEUROTOXIN
NEUROTOXIN
TOG4A_AGEAP
UNP
1
1
P30288
KKKCIAKDYGRCKWGGTPCCRGRGCICSIMGTNCECKPRLIMEGLGLA
1
48
1OAV
1
48
P30288
A
1
1
48
3
anti-parallel
anti-parallel
A
GLY
10
A
GLY
10
A
CYS
12
A
CYS
12
A
CYS
34
A
CYS
34
A
LYS
37
A
LYS
37
A
GLY
24
A
GLY
24
A
CYS
27
A
CYS
27
1
P 1